News

Vertex has added that 69% of people achieved SVR after receiving an 8-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone. 44% of people in

The goal of the strategic alliance is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between MIT

IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products. Impax will market and distribute the products through Global

The guidance issued by the NICE Appraisal Committee noted that Sandoz’s Omnitrope had undertaken head-to-head trials with the reference product as part of its regulatory submission to the

Hisamitsu Pharmaceutical said that the Salonpas Pain Relief Patch/Salonpas Arthritis Pain patches are formulated for the temporary relief of the mild to moderate aches and pains of the

DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induced liver injury as well as effective screening, diagnostic and treatment options.

Updated results of the primary end point (overall survival) showed that the combination of cabazitaxel and prednisone/prednisolone significantly reduced the risk of death by 28% [HR=0.72 (95% CI:

Presidio has said that the inhibitors of the HCV NS5A protein represent an exciting, highly potent class that is distinct from other classes of HCV antivirals that target

PAPs primarily serve uninsured patients who may not qualify for government-funded programs and cannot afford their medications. Because PAPs are offered by pharmaceutical companies that determine program criteria,